Environmental Sustainability
Becoming an environmentally sustainable business
Our ambition is to be a catalyst for positive change and a leader in environmental sustainability.
Our continued investment in our planet supports our purpose to reimagine medicine to improve and extend people’s lives. It is also a way to build trust with society, if our actions are guided by a commitment to transparency and creating enduring change.
Novartis Green Expectations
We invite all our suppliers to join us on our sustainability journey.
Science Based Targets
Novartis is proud to participate in the Science Based Targets initiative, which champions science-based target setting as a powerful way of boosting companies’ competitive advantage in the transition to the low-carbon economy. The initiative is a collaboration between the not-for-profit CDP, United Nations Global Compact (UNGC), World Resources Institute (WRI) and World Wide Fund for Nature (WWF), and is one of the We Mean Business Coalition commitments.
Novartis has committed to set science-based emissions reduction targets across our entire value chain that are consistent with keeping global warming to 1.5°C above pre-industrial levels. Within the scope of this commitment, we have joined Business Ambition for 1.5°C and have also become part of Race to Zero, the UN-backed campaign led by the High-Level Champions for Climate Action.
Our Performance
-
19%
reduction in greenhouse gas emissions (Scope 1 and 2) vs. 2016
-
35%
reduction in water consumption vs. 2016
- CDP Climate Report
- CDP Water Report
- Pharmaceuticals in the Environment
- Novartis carbon-sink Forestry Projects
- Impact valuation of carbon-sink projects report
- 2020 HSE Data Table
- Environmental Sustainability and Occupational Health and Safety Data Supplement 2019
- Novartis Green Expectations from suppliers